According to Future Market Insights research, during the projected period, the global rapid test readers market is expected to grow at a CAGR of 8.8%. The market value is projected to increase from US$ 279.0 Million in 2023 to US$ 645.9 Million by 2033. The rapid test readers market was valued at US$ 258.9 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 7.7% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 258.9 Million |
| Market Value 2023 | US$ 279.0 Million |
| Market Value 2033 | US$ 645.9 Million |
| CAGR 2023 to 2033 | 8.8% |
| Market Share of Top 5 Countries | 67.1% |
| Key Companies List | PerkinElmer Inc., Becton, Dickinson and Company, Abbott, Gold Standard Diagnostics, CTK Biotech, Inc, Siemens Healthineers, VedaLab, ASEBIO, Invitron Ltd, Rapid Test Digital, Indifoss , NewScen Coast Bio-Pharmaceutical Co., Ltd., Innovation Biotech (Beijing) Co.,Ltd |
Recent years have seen a remarkable increase in the market for rapid test readers, which can be attributed to the rising need for effective and precise diagnostic tools. The healthcare and medical industries have changed because of rapid test readers, which are crucial for providing timely and reliable results.
These small, portable gadgets are made to interpret and evaluate rapid diagnostic tests, giving accurate data in a matter of minutes. The market for these readers has seen a spike in acceptance across numerous sectors, including hospitals, clinics, laboratories, and research facilities, as a result of technological developments and the increased requirement for quick and on-the-spot testing.
The demand for prompt illness detection and monitoring, as well as continuing research and development, is projected to drive the growth of the global market for rapid test readers.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global rapid test readers market recorded a historic CAGR of 6.5% in the last 10 years from 2012 to 2022. Rapid test readers market holds around 1.0% of the global point-of-care diagnostics market in 2022.
The rising use of lateral flow assays is a significant market growth factor for rapid test readers. Lateral flow assays are simple, user-friendly diagnostic tests that produce results quickly without the need for expensive laboratory equipment or specialist expertise. These assays are frequently used in diagnostic applications such as infectious disease testing, pregnancy testing, drug testing, and food safety testing.
Several factors influence the use of lateral flow tests. For starters, their ease of use qualifies them for point-of-care testing, when quick results are critical for making timely treatment decisions. Lateral flow assays provide a practical and cost-effective way for healthcare professionals to perform on-site diagnostics, particularly in resource-constrained settings.
Likewise, lateral flow assays based rapid test readers are becoming more popular in home healthcare settings. Patients can readily do these tests at home without the assistance of a healthcare professional, allowing them to self-monitor and treat a variety of health issues. This tendency corresponds to the increasing need for decentralized healthcare solutions and patient empowerment.
Rapid testing market also influences telemedicine and remote monitoring systems (RMS) industry, allowing patients to complete tests remotely and communicate data with healthcare providers for real-time monitoring and diagnosis. This integration improves access to healthcare services and fosters continuity of treatment, especially in rural or disadvantaged areas.
Overall, the growing use of lateral flow assays is increasing the demand for rapid test readers. These readers provide impartial interpretation and analysis of the results, ensuring the lateral flow assay tests' correctness and dependability. The market for rapid test readers is predicted to increase significantly in the next years due to the rising uses and benefits of lateral flow tests (LFT).
Technological advancements are a significant market driver for the rapid test readers market. Continued innovation and development in the field have led to the introduction of highly sophisticated and user-friendly devices.
Integration of advanced technologies such as artificial intelligence (AI), machine learning, and advanced algorithms has enhanced the accuracy, sensitivity, and specificity of rapid test readers. These advancements have resulted in improved performance, faster turnaround times, and enhanced user experience.
The increasing prevalence of Infectious diseases around the globe has resulted in higher uptake of point-of-care diagnostic testing. These testing includes rapid testing for drug of abuse cases in forensics or lateral flow chromatography based immunoassays for qualitative detection of cTnI (cardiac Troponin I) at remote settings among many other testing applications.
These rapid tests are easy to use, ideal to read results and diagnose the conditions on the site. Owed to their rapid diagnosis and easy availability, point-of-care rapid diagnostics are typically the first form of testing recommended worldwide.
Drug abuse testing is frequently employed in forensic and clinical settings. Urine is the recommended specimen type for testing for drugs of abuse, but saliva, perspiration, hair, and meconium are also becoming more popular. The gold standard for confirmatory drug testing has been Rapid Gas Chromatography-Mass Spectrometry (Rapid- GC-MS), however, Liquid Chromatography-tandem-Mass Spectrometry (LC-tandem-MS) can evaluate a wider range of analyses than GC-MS.
The introduction of miniature ambient ionization mass spectrometry, which can evaluate biological samples including urine in one minute, is another technical achievement. As a result, these mass spectrometers show promise for rapid drug abuse detection in a POC setting.
Rapid test readers market growth is being fueled by the constant technological advancement that guarantees healthcare professionals access to cutting-edge diagnostic equipment.
Principal Consultant
The high initial costs involved in designing and producing these devices are one of the factors limiting the market growth for rapid test readers. Research, development, and production infrastructure may need to be heavily invested in order to create reliable and accurate quick test readers.
Components, software development, quality assurance procedures, and regulatory compliance are all included in the price. These prohibitive up-front expenses may discourage start-ups or smaller businesses from entering the market and may reduce the range of accessible options.
Rapid test readers can also be expensive, which limits their usability in healthcare settings with limited resources. This limitation makes it difficult to achieve broad adoption and commercial expansion for rapid test readers.
The USA dominates the global market with 29.8% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
In the United States, a primary market driver for rapid test readers is the increase in demand for point-of-care testing and rapid testing. In a variety of healthcare settings, there is an increasing demand for instantaneous outcomes and on-the-spot diagnostics.
Healthcare practitioners can rapidly and accurately evaluate and analyze the results of rapid diagnostic tests using rapid test readers. Rapid test readers are becoming more popular because of point-of-care testing, which enables tests to be administered at the patient's bedside or in other unconventional healthcare settings.
Real-time readings enable prompt treatment decisions, enhance patient outcomes, and boost overall healthcare productivity. The demand for rapid test readers is fueled by the rising importance of rapid testing in the US, which is helping the market expand.
Germany holds about 32.7% of the market share, within Europe in 2022.
The expanding applications of rapid testing outside of healthcare settings has significantly impacted the rapid test reader market in Germany. Rapid test readers, which were once primarily employed in healthcare settings, are now finding use in many different industries. In Germany, these tools are used in veterinary care, food safety, environmental testing, and drug testing, among other fields.
Rapid test readers are useful tools in various non-healthcare fields due to their adaptability and capacity to give prompt and accurate test result interpretations. In Germany, the expansion of applications outside of healthcare has opened up new market prospects, promoting the use of rapid test readers across many industries and fostering industry expansion.
China holds about 10.2% share in the global market in 2022 and is projected to increase during the forecast period.
Rising demand for home testing has considerably impacted the rapid test readers market in China. Self-testing and home-based healthcare are becoming more popular in the nation. Rapid test readers have been essential in addressing this demand by allowing people to conduct diagnostic tests at the convenience of their own homes.
Home testing has become more and more popular in China due to its accessibility, convenience, and privacy benefits. Rapid test readers enable people to monitor their health and identify specific illnesses without having to go to a healthcare facility by providing accurate and trustworthy interpretations of test results.
Rapid test readers have a sizable market in China thanks to the country's rising need for at-home testing, which has accelerated their uptake and fueled the business.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Portable segment within the modality segment hold a revenue share of 82.3% in 2022, and the same trend is being followed over the forecasted period.
Due to the rising need for on-the-go diagnostics, point-of-care testing, and the convenience of portable devices for immediate and easy test results, the portable segment dominates the modality segment of the market for rapid test readers.
COVID-19 test held a market share of 38.0% in 2022. Due to the global pandemic and the widespread demand for quick and precise testing for the diagnosis and management of COVID-19 transmission, the COVID-19 test segment leads the market for rapid test readers.
Hospitals within the end user segment hold a market share of 54.0% in 2022, within the forecasted period.
Due to the increasing demand for point-of-care testing and the accessibility of advanced healthcare infrastructure in hospitals, which enables efficient and accurate diagnostic testing, the hospitals segment leads the end user segment for rapid test readers.
Key producers of rapid test readers are focusing on strategic collaborations to develop novel product lines and gain large customer base globally
Similarly, recent developments related to companies in rapid test readers market have been tracked by the team at Future Market Insights, which are available in the full report.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Modality, Application, End Users and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The demand for prompt illness detection and monitoring drives market growth.
Abbott, VedaLab, and ASEBIO are the key market players.
China held about 10.2% share of the global market in 2022.
This market is valued at US$ 279.0 million in 2023.
The market was valued at US$ 258.9 million in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation/Development Trends
4. Value Added Insights
4.1. Adoption Rate/Usage Analysis for
4.2. Regulatory Scenario
4.3. PESTLE Analysis
4.4. Government Initiative and Healthcare Policies
4.5. Porter's Analysis
4.6. Recent Product Approvals/Launches
4.7. Unmet Needs
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Diagnostics Testing Market Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Awareness of Rapid Test Readers
5.2.2. Increasing Prevalence of Chronic Disease
5.2.3. Growing Investment in Healthcare Expenditure
5.2.4. Novel Applications
5.2.5. Top Companies’ Historical Growth
5.2.6. Application-Based Cost
5.2.7. Strategic Collaboration and Partnership
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2012 to 2022
6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
8.2. Historical Market Value (US$ Million) Analysis, 2012 to 2022
8.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.3.1. Y-o-Y Growth Trend Analysis
8.3.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Modality
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Modality, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Modality, 2023-2033
9.3.1. Portable
9.3.2. Handheld
9.4. Market Attractiveness Analysis by Modality
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023-2033
10.3.1. COVID-19 Test
10.3.2. Drug of Abuse Test
10.3.3. D-Dimer Test
10.3.4. Procalcitonin Test
10.3.5. C-Reactive Protein (CRP) Test
10.3.6. Myocardial Infarction
10.3.7. Others
10.4. Market Attractiveness Analysis by Application
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis by End User, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Diagnostics Laboratories
11.3.3. Specialty Clinics
11.4. Market Attractiveness Analysis by End User
12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Modality
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Modality
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. U.S Market
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Modality
13.7.1.2.2. By Application
13.7.1.2.3. By End User
13.7.2. Canada Market
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Modality
13.7.2.2.2. By Application
13.7.2.2.3. By End User
14. Latin America Market Analysis 2012 to2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Modality
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Modality
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Brazil Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Modality
14.7.1.2.2. By Application
14.7.1.2.3. By End User
14.7.2. Mexico Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Modality
14.7.2.2.2. By Application
14.7.2.2.3. By End User
14.7.3. Argentina Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast by Market Taxonomy
14.7.3.2.1. By Modality
14.7.3.2.2. By Application
14.7.3.2.3. By End User
15. Europe Market 2012 to2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Spain
15.3.1.4. Italy
15.3.1.5. BENELUX
15.3.1.6. U.K.
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Modality
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Modality
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Germany Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Modality
15.7.1.2.2. By Application
15.7.1.2.3. By End User
15.7.2. France Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Modality
15.7.2.2.2. By Application
15.7.2.2.3. By End User
15.7.3. Spain Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Modality
15.7.3.2.2. By Application
15.7.3.2.3. By End User
15.7.4. Italy Market Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Modality
15.7.4.2.2. By Application
15.7.4.2.3. By End User
15.7.5. BENELUX Market Analysis
15.7.5.1. Introduction
15.7.5.2. Market Analysis and Forecast by Market Taxonomy
15.7.5.2.1. By Modality
15.7.5.2.2. By Application
15.7.5.2.3. By End User
15.7.6. U.K Market Analysis
15.7.6.1. Introduction
15.7.6.2. Market Analysis and Forecast by Market Taxonomy
15.7.6.2.1. By Modality
15.7.6.2.2. By Application
15.7.6.2.3. By End User
15.7.7. Russia Market Analysis
15.7.7.1. Introduction
15.7.7.2. Market Analysis and Forecast by Market Taxonomy
15.7.7.2.1. By Modality
15.7.7.2.2. By Application
15.7.7.2.3. By End User
16. East Asia Market Analysis 2012 – 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Modality
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Modality
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Modality
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Modality
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Modality
16.8.3.2.2. By Application
16.8.3.2.3. By End User
17. South Asia Market Analysis 2012 – 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Thailand
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Modality
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Modality
17.4.2. By Application
17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Modality
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. Indonesia Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Modality
17.7.2.2.2. By Application
17.7.2.2.3. By End User
17.7.3. Thailand Market Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Modality
17.7.3.2.2. By Application
17.7.3.2.3. By End User
17.7.4. Malaysia Market Analysis
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Modality
17.7.4.2.2. By Application
17.7.4.2.3. By End User
18. Oceania Market Analysis 2012 – 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Modality
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Modality
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Australia Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Modality
18.7.1.2.2. By Application
18.7.1.2.3. By End User
18.7.2. New Zealand Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Modality
18.7.2.2.2. By Application
18.7.2.2.3. By End User
19. Middle East & Africa Market Analysis 2012 – 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of MEA
19.3.2. By Modality
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Modality
19.4.3. By Application
19.4.4. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. GCC Countries Market Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Modality
19.7.1.2.2. By Application
19.7.1.2.3. By End User
19.7.2. Türkiye Market Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Modality
19.7.2.2.2. By Application
19.7.2.2.3. By End User
19.7.3. Northern Africa Market Analysis
19.7.3.1. Introduction
19.7.3.2. Market Analysis and Forecast by Market Taxonomy
19.7.3.2.1. By Modality
19.7.3.2.2. By Application
19.7.3.2.3. By End User
19.7.4. South Africa Market Analysis
19.7.4.1. Introduction
19.7.4.2. Market Analysis and Forecast by Market Taxonomy
19.7.4.2.1. By Modality
19.7.4.2.2. By Application
19.7.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional footprint of Players
20.3.2. Product footprint by Players
20.3.3. Channel footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. PerkinElmer Inc.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. Sales Footprint
21.3.1.5. SWOT Analysis
21.3.1.6. Key Developments
21.3.1.7. Strategy Overview
21.3.1.7.1. Channel Strategy
21.3.1.7.2. Marketing Strategy
21.3.1.7.3. Product Strategy
21.3.2. Becton, Dickinson and Company
21.3.3. Abbott
21.3.4. Gold Standard Diagnostics
21.3.5. CTK Biotech, Inc
21.3.6. Siemens Healthineers
21.3.7. VedaLab
21.3.8. ASEBIO
21.3.9. Invitron Ltd
21.3.10. Rapid Test Digital
21.3.11. Indifoss
21.3.12. NewScen Coast Bio-Pharmaceutical Co., Ltd.
21.3.13. Innovation Biotech (Beijing) Co.,Ltd
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Rapid Test Readers Market
